About: Mecasermin rinfabate

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Mecasermin rinfabate (INN, USAN) (brand name Iplex), also known as rhIGF-1/rhIGFBP-3, is a drug consisting of recombinant human insulin-like growth factor 1 (IGF-1) and recombinant human insulin-like growth factor binding protein-3 (IGFBP-3) which is used for the treatment of amyotrophic lateral sclerosis (Lou Gehrig's disease). It is similar in action to mecasermin, but with fewer side effects (such as hypoglycemia).

Property Value
dbo:abstract
  • Mecasermin rinfabate (INN, USAN) (brand name Iplex), also known as rhIGF-1/rhIGFBP-3, is a drug consisting of recombinant human insulin-like growth factor 1 (IGF-1) and recombinant human insulin-like growth factor binding protein-3 (IGFBP-3) which is used for the treatment of amyotrophic lateral sclerosis (Lou Gehrig's disease). It is similar in action to mecasermin, but with fewer side effects (such as hypoglycemia). (en)
  • Mecasermina rinfabato (nome commerciale IPLEX ) è un farmaco composto da ricombinante Insulin-like growth factor 1 (IGF-1) e binding protein-3 (insulin-like growth factor ). Si crede di essere simile in effetti a mecasermina, ma con minori effetti collaterali quali l'ipoglicemia. (it)
dbo:alternativeName
  • Iplex (en)
dbo:fdaUniiCode
  • NZ8M50KKRG
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 11274133 (xsd:integer)
dbo:wikiPageLength
  • 10567 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1108874916 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • H01 (en)
dbp:atcSuffix
  • AC05 (en)
dbp:chemspiderid
  • none (en)
dbp:class
dbp:component
  • IGF-1 (en)
  • IGFBP-3 (en)
dbp:routesOfAdministration
  • Injection (en)
dbp:tradename
  • Iplex (en)
dbp:type
  • combo (en)
dbp:unii
  • NZ8M50KKRG (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 447774121 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Mecasermin rinfabate (INN, USAN) (brand name Iplex), also known as rhIGF-1/rhIGFBP-3, is a drug consisting of recombinant human insulin-like growth factor 1 (IGF-1) and recombinant human insulin-like growth factor binding protein-3 (IGFBP-3) which is used for the treatment of amyotrophic lateral sclerosis (Lou Gehrig's disease). It is similar in action to mecasermin, but with fewer side effects (such as hypoglycemia). (en)
  • Mecasermina rinfabato (nome commerciale IPLEX ) è un farmaco composto da ricombinante Insulin-like growth factor 1 (IGF-1) e binding protein-3 (insulin-like growth factor ). Si crede di essere simile in effetti a mecasermina, ma con minori effetti collaterali quali l'ipoglicemia. (it)
rdfs:label
  • Mecasermina rinfabato (it)
  • Mecasermin rinfabate (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License